Aberrant expression of cyclin A correlates with morphogenesis of Reed-Sternberg cells in Hodgkin lymphoma

American Journal of Clinical Pathology

Volumn 132, Issue 1, 2009, Pages 50-59

  Chang, Kung Chao ^a   Chang, Yao ^b   Jones, Dan ^c   Su, Ih Jen ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aberrant expression; Cyclin A; Epstein Barr virus; Hodgkin lymphoma; Latent membrane protein 1

Indexed keywords

CD15 ANTIGEN; CD30 ANTIGEN; CD99 ANTIGEN; CYCLIN A; EPSTEIN BARR VIRUS ENCODED RNA; LATENT MEMBRANE PROTEIN 1; RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MORPHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; STAINING;

ADULT; CELL LINE, TUMOR; CYCLIN A; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GIANT CELLS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; MALE; REED-STERNBERG CELLS; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; VIRAL MATRIX PROTEINS;

EID: 67650471361     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPBDFR5L5UOAUZ     Document Type: Article

References (34)

1. Diehl V, Thomas RK, Re D. Part II: Hodgkin's lymphoma: diagnosis and treatment. Lancet Oncol. 2004;5:19-26.
2. Rosai J. Rosai and Ackerman's Surgical Pathology. 9th ed. Philadelphia, PA: Mosby; 2004.
3. Bai M, Papoudou-Bai A, Kitsoulis P, et al. Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas. In Vivo. 2005;19:439-453.
4. Tzankov A, Zimpfer A, Went P, et al. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma. Mod Pathol. 2005;18:90-96.
5. Kim SH, Choi EY, Shin YK, et al. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2). Blood. 1998;92:4287-4295.
6. Knecht H, McQuain C, Martin J, et al. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene. 1996;13:947-953.
7. Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
8. Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest. 2003;111:529-537.
9. Schwering I, Brauninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2003;101:1505-1512.
10. Kim SH, Shin YK, Lee IS, et al. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Blood. 2000;95:294-300.
11. Vockerodt M, Morgan SL, Kuo M, et al. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype. J Pathol. 2008;216:83-92.
12. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7:270-280.
13. Ching YP, Chan SF, Jeang KT, et al. The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol. 2006;8:717-724.
14. Santiago F, Clark E, Chong S, et al. Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J Virol. 1999;73:9917-9927.
15. Faivre J, Frank-Vaillant M, Poulhe R, et al. Centrosome overduplication, increased ploidy and transformation in cells expressing endoplasmic reticulum-associated cyclin A2. Oncogene. 2002;21:1493-1500.
16. Wang HC, Chang WT, Chang WW, et al. Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology. 2005;41:761-770.
17. Davy CE, Ayub M, Jackson DJ, et al. HPV16 E1-E4 protein is phosphorylated by Cdk2/cyclin A and relocalizes this complex to the cytoplasm. Virology. 2006;349:230-244.
18. Aaltomaa S, Eskelinen M, Lipponen P. Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival. Prostate. 1999;38:175-182.
19. Chang KC, Khen NT, Jones D, et al. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. Hum Pathol. 2005;36:747-755.
20. Tsai ST, Jin YT, Wu TC. Synthesis of PCR-derived, digoxigenin-labeled DNA probes for in situ detection of Epstein-Barr early RNAs in Epstein-Barr virus-infected cells. J Virol Methods. 1995;54:67-74.
21. Chuang H-C, Lay J-D, Hsieh W-C, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood. 2005;106:3090-3096.
22. Chang Y, Lee HH, Chang SS, et al. Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. J Virol. 2004;78:13028-13036.
23. de La Fuente C, Santiago F, Chong SY, et al. Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2. J Virol. 2000;74:7270-7283.
24. Wang HC, Wu HC, Chen CF, et al. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol. 2003;163:2441-2449.
25. Tsang WY, Wang L, Chen Z, et al. SCAPER, a novel cyclin A-interacting protein that regulates cell cycle progression. J Cell Biol. 2007;178:621-633.
26. Jackman M, Kubota Y, den Elzen N, et al. Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Mol Biol Cell. 2002;13:1030-1045.
27. Ohshima K, Haraoka S, Fujiki T, et al. Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression. Pathol Int. 1999;49:506-512.
28. Re D, Thomas RK, Behringer K, et al. From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential. Blood. 2005;105:4553-4560.
29. Benharroch D, Shemer-Avni Y, Levy A, et al. New candidate virus in association with Hodgkin's disease. Leuk Lymphoma. 2003;44:605-610.
30. Jarrett RF, MacKenzie J. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease. Semin Hematol. 1999;36:260-269.
31. Nerurkar AY, Vijayan P, Srinivas V, et al. Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis. Ann Oncol. 2000;11:475-478.
32. Pettersen RD, Bernard G, Olafsen MK, et al. CD99 signals caspase-independent T cell death. J Immunol. 2001;166:4931-4942.
33. Hirsch B, Hummel M, Bentink S, et al. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells. Am J Pathol. 2008;172:510-520.
34. Staber PB, Noehammer C, Durkop H, et al. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma. Leuk Res. 2006;30:343-348.